Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: A meta-analysis of 862 children

Pediatrics

Volumn 116, Issue 4, 2005, Pages 989-995

  Wooditch, Angela C ^a   Aronoff, Stephen C ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Complications; Coronary aneurysms; Corticosteroids; Kawasaki disease; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; CEFALEXIN; CORTICOSTEROID; DIPYRIDAMOLE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; PROPRANOLOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ARTICLE; CATHETERIZATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DRUG DOSE REGIMEN; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; GENETIC HETEROGENEITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VASCULITIS; DRUG COMBINATION;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CORONARY ANEURYSM; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 33644665487     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2005-0504     Document Type: Article

References (33)

1. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki's disease. Diagnostic guidelines for Kawasaki disease. Am J Dis Child. 1990;144:1218-1219
2. Kawasaki T, Kosaki F, Okawa S, et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271-276
3. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708-1733
4. Nakamura Y, Nagai M, Yanagawa H, et al. Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics. 1991;88:1144-1147
5. Durongpisitkul K, Guruuraj V, Martin C. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96:1057-1061
6. Shulman S. Is there a role for corticosteroids in Kawasaki disease? J Pediatr. 2003;142:601-603
7. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In: Egger M, Davey Smith G, Altman D, eds. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London, United Kingdom: BMJ Publishing Group; 2001:285-312
8. Thompson S. Why and how sources of heterogeneity should be investigated. In: Egger M, Davey Smith G, Altman D, eds. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London, United Kingdom: BMJ Publishing Group; 2001:157-175
9. Cochrane W. The combination of estimates from different experiments. Biometrics. 1954;10:101-129
10. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560
11. Galbraith R. A note on the graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7:889-894
12. Smith GD, Egger M. Going beyond the mean: subgroup analysis in meta-analysis of randomised trials. In: Egger M, Davey Smith G, Altman D, eds. Systematic Reviews in Health Care: Meta-analysis In context. 2nd ed. London, United Kingdom: BMJ Publishing Group; 2001:143-156
13. Sterne JAC, Eggers M, Davey Smith G. Investigating and dealing with publication and other bias. In: Egger M, Davey Smith G, Altman D, eds. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London, United Kingdom: BMJ Publishing Group; 2001:189-208
14. Rosenthal R. The "file drawer" problem and tolerance for null results. Psychol Bull. 1979;86:638-641
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-747
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188
17. Dale RC, Saleem M, Daw S, et al. Treatment of severe complicated Kawasaki disease with prednisolone and aspirin. J Pediatr. 2000;137:723-726
18. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int. 2001;43:211-217
19. Wright DA, Newburger J, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996;128:146-149
20. Nonaka Z, Maekawa K, Okabe T, et al. Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki disease. In: H Kato, ed. 5th International Kawasaki Disease Symposium; 1995; Fukoka Japan. Tokyo, Japan: Elsevier; 1995:328-331
21. Kijima Y, Kamiya T, Suzuki A, et al. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J. 1982;46:1239-1242
22. Kan Z, Nonaka Z. Reevaluation of steroid therapy in MCLS. J Pediatr Pract. 1984;47:1367-1371
23. Kan Z, Hashino K. Effectiveness of steroid-aspirin combined therapy for Kawasaki disease. J Pediatr Pract. 1990;53:328-331
24. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics. 1979;63:175-179
25. Kusakawa S. Long-term administrative care of Kawasaki disease. Acta Paediatr Jap. 1983;25:205-209
26. Neudorf U. New therapeutic aspects in Kawasaki syndrome and personal experiences [in German]. Infusionsther Transfusionsmed. 1993;20(suppl 1):137-139
27. Okada Y, Shinohara M, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr. 2003;143:363-367
28. Shinohara M, Sone K, Tomomasa T, et al. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr. 1999;135:465-469
29. Sone K, Suzuki A. Multidrug therapy for MCLS. J Pediatr Pract. 1987;50:1175-1180
30. Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr. 2003;142:611-616
31. LeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med. 1997;337:536-542
32. Cappelleri JC, Ioannidis JPA, Schmid CH et al. Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA. 1996;276:1332-1338
33. Newburger JW. Treatment of Kawasaki disease: corticosteroids revisited. J Pediatr. 1999;135:411-413